These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 12492745

  • 1. Pantoprazole maintenance therapy prevents relapse of erosive oesophagitis.
    Metz DC, Bochenek WJ, Pantoprazole US GERD Study Group.
    Aliment Pharmacol Ther; 2003 Jan; 17(1):155-64. PubMed ID: 12492745
    [Abstract] [Full Text] [Related]

  • 2. Prevention of erosive oesophagitis relapse with pantoprazole.
    Richter JE, Fraga P, Mack M, Sabesin SM, Bochenek W, Pantoprazole US GERD Study Group.
    Aliment Pharmacol Ther; 2004 Sep 01; 20(5):567-75. PubMed ID: 15339328
    [Abstract] [Full Text] [Related]

  • 3. Comparison of the efficacy of pantoprazole vs. nizatidine in the treatment of erosive oesophagitis: a randomized, active-controlled, double-blind study.
    Kovacs TO, Wilcox CM, DeVault K, Miska D, Bochenek W, Pantoprozole US Gerd Study Group B.
    Aliment Pharmacol Ther; 2002 Dec 01; 16(12):2043-52. PubMed ID: 12452936
    [Abstract] [Full Text] [Related]

  • 4. [Clinical superiority of pantoprazole over ranitidine in the treatment of reflux esophagitis grade II and III. A prospective, double-blind, double-placebo study. Mexican clinical experience. Mexican Pantoprazole Study Group].
    Gallo S, Dibildox M, Moguel A, Di Silvio M, Rodríguez F, Almaguer I, García C.
    Rev Gastroenterol Mex; 1998 Dec 01; 63(1):11-6. PubMed ID: 10068743
    [Abstract] [Full Text] [Related]

  • 5. Esomeprazole 20 mg vs. pantoprazole 20 mg for maintenance therapy of healed erosive oesophagitis: results from the EXPO study.
    Labenz J, Armstrong D, Lauritsen K, Katelaris P, Schmidt S, Schütze K, Wallner G, Juergens H, Preiksaitis H, Keeling N, Nauclér E, Adler J, Eklund S.
    Aliment Pharmacol Ther; 2005 Nov 01; 22(9):803-11. PubMed ID: 16225489
    [Abstract] [Full Text] [Related]

  • 6. Pantoprazole 20 mg is effective for relief of symptoms and healing of lesions in mild reflux oesophagitis.
    Dettmer A, Vogt R, Sielaff F, Lühmann R, Schneider A, Fischer R.
    Aliment Pharmacol Ther; 1998 Sep 01; 12(9):865-72. PubMed ID: 9768529
    [Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of pantoprazole versus ranitidine in the treatment of patients with symptomatic gastroesophageal reflux disease.
    van Zyl J, van Rensburg C, Vieweg W, Fischer R.
    Digestion; 2004 Sep 01; 70(1):61-9. PubMed ID: 15297779
    [Abstract] [Full Text] [Related]

  • 8. Relapse prevention in reflux oesophagitis with regard to Helicobacter pylori status: a double-blind, randomized, multicentre trial to compare the efficacy of pantoprazole versus ranitidine.
    Adamek RJ, Behrendt J, Wenzel C.
    Eur J Gastroenterol Hepatol; 2001 Jul 01; 13(7):811-7. PubMed ID: 11474311
    [Abstract] [Full Text] [Related]

  • 9. Pantoprazole provides rapid and sustained symptomatic relief in patients treated for erosive oesophagitis.
    Bochenek WJ, Mack ME, Fraga PD, Metz DC.
    Aliment Pharmacol Ther; 2004 Nov 15; 20(10):1105-14. PubMed ID: 15569113
    [Abstract] [Full Text] [Related]

  • 10. Maintenance therapy with pantoprazole 20 mg prevents relapse of reflux oesophagitis.
    Escourrou J, Deprez P, Saggioro A, Geldof H, Fischer R, Maier C.
    Aliment Pharmacol Ther; 1999 Nov 15; 13(11):1481-91. PubMed ID: 10571605
    [Abstract] [Full Text] [Related]

  • 11. Short- and long-term therapy for reflux oesophagitis in the elderly: a multi-centre, placebo-controlled study with pantoprazole.
    Pilotto A, Leandro G, Franceschi M, Ageing and Acid-Related Disease Study Group.
    Aliment Pharmacol Ther; 2003 Jun 01; 17(11):1399-406. PubMed ID: 12786634
    [Abstract] [Full Text] [Related]

  • 12. Healing and relapse rates in gastroesophageal reflux disease treated with the newer proton-pump inhibitors lansoprazole, rabeprazole, and pantoprazole compared with omeprazole, ranitidine, and placebo: evidence from randomized clinical trials.
    Caro JJ, Salas M, Ward A.
    Clin Ther; 2001 Jul 01; 23(7):998-1017. PubMed ID: 11519776
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and tolerability of 20 mg pantoprazole versus 300 mg ranitidine in patients with mild reflux-oesophagitis: a randomized, double-blind, parallel, and multicentre study.
    van Zyl JH, de K Grundling H, van Rensburg CJ, Retief FJ, O'Keefe SJ, Theron I, Fischer R, Bethke T.
    Eur J Gastroenterol Hepatol; 2000 Feb 01; 12(2):197-202. PubMed ID: 10741935
    [Abstract] [Full Text] [Related]

  • 14. Pantoprazole. A review of its pharmacological properties and therapeutic use in acid-related disorders.
    Fitton A, Wiseman L.
    Drugs; 1996 Mar 01; 51(3):460-82. PubMed ID: 8882382
    [Abstract] [Full Text] [Related]

  • 15. One-year prophylactic efficacy and safety of pantoprazole in controlling gastro-oesophageal reflux symptoms in patients with healed reflux oesophagitis.
    Mössner J, Koop H, Porst H, Wübbolding H, Schneider A, Maier C.
    Aliment Pharmacol Ther; 1997 Dec 01; 11(6):1087-92. PubMed ID: 9663834
    [Abstract] [Full Text] [Related]

  • 16. Intravenous pantoprazole as initial treatment in patients with gastroesophageal reflux disease and a history of erosive esophagitis: a randomized clinical trial.
    Pratha V, Hogan DL, Lynn RB, Field B, Metz DC.
    Dig Dis Sci; 2006 Sep 01; 51(9):1595-601. PubMed ID: 16927137
    [Abstract] [Full Text] [Related]

  • 17. A comparison of omeprazole, lansoprazole and pantoprazole in the maintenance treatment of severe reflux oesophagitis.
    Jaspersen D, Diehl KL, Schoeppner H, Geyer P, Martens E.
    Aliment Pharmacol Ther; 1998 Jan 01; 12(1):49-52. PubMed ID: 9692700
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and tolerability of pantoprazole versus ranitidine in the treatment of reflux esophagitis and the influence of Helicobacter pylori infection on healing rate.
    Meneghelli UG, Boaventura S, Moraes-Filho JP, Leitão O, Ferrari AP, Almeida JR, Magalhães AF, Castro LP, Haddad MT, Tolentino M, Jorge JL, Silva E, Maguilnik I, Fischer R.
    Dis Esophagus; 2002 Jan 01; 15(1):50-6. PubMed ID: 12060043
    [Abstract] [Full Text] [Related]

  • 19. A double-blind study of pantoprazole and ranitidine in treatment of acute duodenal ulcer. A multicenter trial. European Pantoprazole Study Group.
    Cremer M, Lambert R, Lamers CB, Delle Fave G, Maier C.
    Dig Dis Sci; 1995 Jun 01; 40(6):1360-4. PubMed ID: 7781461
    [Abstract] [Full Text] [Related]

  • 20. Randomised controlled trial of pantoprazole versus ranitidine for the treatment of uninvestigated heartburn in primary care.
    Talley NJ, Moore MG, Sprogis A, Katelaris P.
    Med J Aust; 2002 Oct 21; 177(8):423-7. PubMed ID: 12381251
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.